---
title: "Solésence reports Q2 2026 revenue of $15.3M, net loss $0.16M; adjusted EBITDA $0.52M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296517384.md"
description: "Solésence reported Q2 2026 net revenue of $15.3 million, down from $20.4 million in the prior year, resulting in a net loss of $0.16 million compared to a net income of $3.2 million previously. Gross profit was $4.7 million with a 31% margin, and adjusted EBITDA stood at $0.52 million. The company completed an evaluation of inventory costing methodologies and filed its Form 10-Q."
datetime: "2026-08-20T16:13:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296517384.md)
  - [en](https://longbridge.com/en/news/296517384.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296517384.md)
generator: "portal-rs"
---

# Solésence reports Q2 2026 revenue of $15.3M, net loss $0.16M; adjusted EBITDA $0.52M

Solésence reported second-quarter 2026 net revenue of $15.3 million and a net loss of $0.16 million, compared with net revenue of $20.4 million and net income of $3.2 million in the year-ago quarter. Gross profit for the quarter was $4.7 million with a gross margin of 31%, and adjusted EBITDA was $0.52 million for the three months ended June 30, 2026. The company said it completed an evaluation of historical inventory costing allocation methodologies and filed its Form 10-Q for the quarter.

**Financial Highlights**

-   Net revenue: $15.3 million for the three months ended June 30, 2026 (compared with $20.4 million in Q2 2025).
-   Gross profit: $4.7 million for Q2 2026; gross margin of 31% (32% in Q2 2025).
-   Operating result: Income from operations of $0.12 million for Q2 2026 (operating income was $2.48 million in Q2 2025).
-   Net (loss) income: $(0.16) million for Q2 2026 versus net income of $3.23 million in Q2 2025.
-   Adjusted EBITDA (non-GAAP): $0.52 million for the three months ended June 30, 2026.

**Business Highlights**

-   The company continued execution of its "Transform and Transcend" strategy focused on leveraging intellectual property to enter high-growth markets and expand co-marketing initiatives with partner brands.
-   Management emphasized operational execution and targeted efficiency initiatives to keep the business lean and agile for long-term value creation.
-   Reported progress on corporate governance and reporting controls by completing an evaluation of historical inventory costing allocation methodologies and filing the Form 10-Q for the quarter.
-   Conference call held to discuss results and strategy, featuring the president & CEO and the CFO, with webcast and dial-in access for investors and analysts.

Original SEC Filing: SOLESENCE, INC. \[ SLSN \] - 8-K - Aug. 20, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [SLSN.US](https://longbridge.com/en/quote/SLSN.US.md)

## Related News & Research

- [SLSN: Revenue down in Q2 2026, but full-year growth and record second-half performance expected](https://longbridge.com/en/news/296407231.md)
- [Solésence says prior financial statements no longer reliable after inventory accounting errors found](https://longbridge.com/en/news/296639029.md)
- [Solesence delays quarterly 10-Q filing after discovering improper inventory costing method](https://longbridge.com/en/news/295972000.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [Itera ASA to present preliminary Q2 2026 results via webcast](https://longbridge.com/en/news/296590225.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**